Abstract:AIM: To identify hepatocellular carcinoma (HCC) antigens by serological analysis of recombinant cDNA expression library (SEREX) and observe the expression of hcct-19 in human tissues and cell lines. METHODS: Firstly,a high-quality cDNA library from human HCC tissue was constructed successfully. E.coli transfected with recombinant λTripleX2 phages were plated onto LBagar plates. The expression of recombinant proteins was induced with isopropyl-beta-D-thiogalactopyranoside (IPTG). The membranes were blocked with BSA and incubated with a 1 :1000 dilution of patient's serum, which had been preabsorbed with transfected E.coli phage lysate. Then they were incubated with a 1:5000 dilution of the alkaline phosphatase-conjugated antibody specific for human IgG. Reactive clones were visualized by staining with BCIP/NBT, and these clones were subcloned three times to obtain monoclonality. Secondly, positive clone plaques were randomly picked and tested using polymerase chain reaction (PCR) with universal primers derived from the sequence flanking the vector. PCR products were purified and sequenced, and the results were analyzed with BLAST software in comparison with the known genes in GenBank. Thirdly, the positive clone of hcct-19 gene expression was detected by PCR in normal human tissues of stomach, colon,liver, pancreas, kidney, uterus, testicle and bladder, human tumor tissues of colon carcinoma, renal carcinoma, pancreatic cancer, gastric carcinoma, prostatic carcinoma, HCC, ovarian cancer and lung cancer, and tumor cell lines of HepG2, Hela, MGC-803, PANC-1, PC3, W-549 and SW-480, and semi-quantitative reverse transcription PCR was used to detect hcct-19 expression in HCC and cancer-adjacent tissues. RESULTS: Firstly, thirty-one positive clones were obtained, representing fourteen different cDNA sequences (lengths from 324 to 805 bp). Ten cDNAs were genes with known functions, of which replication factor C2, NADH dehydrogenase 1 alpha subcomplex 4 and mitochondrial carrier triple repeat 1 were found to be associated with HCC for the first time. Secondly, the cloned hcct-19 was expressed in normal human tissues of stomach, large intestine, liver, pancreas, kidney, uterus, testicle and bladder, human rumor tissues of colon carcinoma, renal carcinoma, pancreatic cancer, gastric carcinoma, prostatic carcinoma, hepatocellular carcinoma, ovarian cancer and lung cancer, and tumor cell lines of HepG2,Hela, MGC-803, PANC-1, PC3, W-549 and SW-480. The level of hcct-19 expression in HCC tissues was significantly higher than that in cancer-adjacent tissues (13.2×2.7 vs 2.9×0.3, P<0.05). CONCLUSION: HCC antigens identified from this study contribute to clarify the pathogenesis of HCC, during which hcct-19 may serves as an overexpressed gene.

Construction of Eukaryotic Vector Expressing Antisense RNA of Hepatoma Associated Antigen-Hab18g and Clone Identification

Bc047440 Antisense Eukaryotic Expression Vectors Inhibited Hepg(2) Cell Proliferation and Suppressed Xenograft Tumorigenicity

Construction and Identification of an Antisense Glucose Transporter-1 Plasmid

Inhibitory Effects of Antisense RNA of HAb18G/CD147 on Invasion of Hepatocellular Carcinoma Cells in Vitro.

Construction and identification of vector against Kir6.2 gene expression in hepatoma cells by short interfering RNAs

ESTABLISHMENT OF CHO CELL STRAIN THAT CAN HIGHLY EFFICIENTLY EXPRESS HEPATOMA ASSOCIATE ANTIGEN HAb18G

The Construction and Expression of Eukaryotic EGFP Expression Vector Containing Hepatoma Assosciated Antigen HAb18G/CD147

High Expression of Hepatoma Associated Antigen HAb18G in Prokaryotic Cells and Study on Its Function in Vitro

Construction of hepatocellular specific preS2 antisense RNA expression vector and study of its inhibitory effect

[Cloning and Expression of Fab Gene of Mab HAb18 Against Human Hepatocellular Carcinoma].

Construction of Recombinant Retrovirus Vector Bearing Antisense AFP Enhancer/tk Gene and Its Hepatocyte-Specific Expression

Construction, identification and biological feature study of human hepatocellular carcinoma cells stably expressing HBeAg

Construction and Identification of Small Hairpin RNA Vector Targeting HBV Core Protein in HepG2.2.15 Cells

Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma

Construction of an Engineering Chimeric Antibody Against Human Hepatoma and Stable Expression in Sp2/0 Cell

Identification of hepatocellular carcinoma antigens by serological analysis of recombinant cDNA expression library and detection of hcct-19 expression in human tissues and cell lines

[Construction and Expression of Eukaryotic Expression Plasmid Pcdna3.1/hil-18].

Construction and Identification of Lentiviral Vector of Sirna Specific for CTGF

Construction of a Regulatable Gene Therapy Vector Specific for Hepatocellular Carcinoma

A Novel HBV Antisense RNA Gene Delivery System Targeting Hepatocellular Carcinoma

Construction and Identification of Eukaryotic Expression Vector Pcdna3.1 (+)-ABCG2